Halozyme Therapeutics Inc (HALO)

[Fred Kadiddlehopper]

Agreed, Maumar. It just could be the standard under-promise/over-deliver tack that he's employing. That being said, he did say something about "initial stocking orders" which may have some significance.

Re:FOTD's post, I will gladly defer to Rod when it comes to hard nosed number crunching. In my mind I use 5% for rough guidance in all deals heretofore. Thus if we assume he's under-promising, and using $35 million sales per Q, we can figure on about $7 million from BAX this year. Time will tell.
Good luck!
-Fritz